Difference between revisions of "Standardized Uptake Value (SUV)"
Jump to navigation
Jump to search
Line 9: | Line 9: | ||
*Image data collated and compared to DICOM header information | *Image data collated and compared to DICOM header information | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Working Documents== | ==Working Documents== | ||
Line 47: | Line 19: | ||
[[Media:QIBA_FDG_Vendor_SUV_20081103_DAC_JTY.doc]] Letter with additional questions from Jeff Yap | [[Media:QIBA_FDG_Vendor_SUV_20081103_DAC_JTY.doc]] Letter with additional questions from Jeff Yap | ||
− | |||
== Vendor responses on SUV computation == | == Vendor responses on SUV computation == | ||
Line 58: | Line 29: | ||
* MIMvista - [[Media:MIMvista_QIBA_FDG_Vendor_SUV_20081103_DAC-2.doc]] | * MIMvista - [[Media:MIMvista_QIBA_FDG_Vendor_SUV_20081103_DAC-2.doc]] | ||
+ | |||
+ | == Vendor supplied information == | ||
==Subcommittee Call Summaries== | ==Subcommittee Call Summaries== | ||
Line 67: | Line 40: | ||
*[[Media:03.27.2009 QIBA FDG-PET DRO Call Summary-FINAL.pdf|03.27.2009 FDG-PET/CT DRO Subcommittee Call Summary]] | *[[Media:03.27.2009 QIBA FDG-PET DRO Call Summary-FINAL.pdf|03.27.2009 FDG-PET/CT DRO Subcommittee Call Summary]] | ||
*[[Media:03.13.2009 QIBA FDG-PET DRO Call Summary-FINAL.pdf|03.13.2009 FDG-PET/CT DRO Subcommittee Call Summary]] | *[[Media:03.13.2009 QIBA FDG-PET DRO Call Summary-FINAL.pdf|03.13.2009 FDG-PET/CT DRO Subcommittee Call Summary]] | ||
+ | |||
+ | ==SUV Subcommittee Members== | ||
+ | *'''Paul Kinahan, PhD''', Subcommittee Co-chair <kinahan@u.washington.edu> | ||
+ | * '''David Clunie, MBBS''', Subcommittee Co-chair <dclunie@radpharm.com> | ||
+ | * Ronald Boellaard, PhD <r.boellaard@vumc.nl> | ||
+ | * Michael Casey, PhD <michael.e.casey@siemens.com> | ||
+ | * Paul E. Christian <Paul.Christian@hci.utah.edu> | ||
+ | * Patricia E. Cole, PhD, MD <patriciaellencole@gmail.com> | ||
+ | * Simon DeBruin, MSEE <sdebruin@segamicorp.com> | ||
+ | * John M. Hoffman, MD <john.hoffman@hci.utah.edu> | ||
+ | * Steve Kohlmyer <Steve.Kohlmyer@med.ge.com> | ||
+ | * Piotr Maniawski <piotr.maniawski@philips.com> | ||
+ | * Dennis Nelson, PhD <dnelson@mimvista.com> | ||
+ | * Eric S. Perlman, MD <perlman@radpharm.com> | ||
+ | * Ling X. Shao, PhD, <ling.shao@philips.com> | ||
+ | * John G. Wolodzko, PhD <wolodzko@radpharm.com> | ||
+ | * Jeffrey Yap, PhD <Jeffrey_Yap@dfci.harvard.edu> | ||
+ | * Brian Zimmerman, PhD <bez@nist.gov> |
Revision as of 11:44, 2 October 2012
Back to FDG-PET
QIBA FDG-PET/CT Standardized Uptake Value (SUV) Technical Subcommittee Charge
The objective of this subcommittee is to build a common reference DICOM test image that can be generated by each scanner and read on PET DICOM display stations to check information fidelity (i.e. next step beyond DICOM conformance statement)
Completed:
- Collected DICOM PET/CT images of the same reference phantom from scanners from GE, Philips, Siemens
- Image data collated and compared to DICOM header information
Working Documents
- Digital Reference Objects - 4 Slide Overview - 2009.03.10
- Vendor-neutral pseudo-code for SUV calculation - updated 20091106
Letter to vendors requesting detailed SUV computation description
Media:QIBA_FDG_Vendor_SUV_20081103_DAC.doc Letter sent to vendors
Media:QIBA_FDG_Vendor_SUV_20081103_DAC_JTY.doc Letter with additional questions from Jeff Yap
Vendor responses on SUV computation
- Philips - Media:QIBA_FDG_Vendor_SUV_Philips.doc
Vendor supplied information
Subcommittee Call Summaries
- 11.05.2009 FDG-PET/CT SUV Subcommittee Call Summary
- 09.30.2009 FDG-PET/CT SUV Subcommittee Call Summary
- 08.06.2009 FDG-PET/CT SUV Subcommittee Call Summary
- 04.17.2009 FDG-PET/CT DRO Subcommittee Call Summary
- 03.27.2009 FDG-PET/CT DRO Subcommittee Call Summary
- 03.13.2009 FDG-PET/CT DRO Subcommittee Call Summary
SUV Subcommittee Members
- Paul Kinahan, PhD, Subcommittee Co-chair <kinahan@u.washington.edu>
- David Clunie, MBBS, Subcommittee Co-chair <dclunie@radpharm.com>
- Ronald Boellaard, PhD <r.boellaard@vumc.nl>
- Michael Casey, PhD <michael.e.casey@siemens.com>
- Paul E. Christian <Paul.Christian@hci.utah.edu>
- Patricia E. Cole, PhD, MD <patriciaellencole@gmail.com>
- Simon DeBruin, MSEE <sdebruin@segamicorp.com>
- John M. Hoffman, MD <john.hoffman@hci.utah.edu>
- Steve Kohlmyer <Steve.Kohlmyer@med.ge.com>
- Piotr Maniawski <piotr.maniawski@philips.com>
- Dennis Nelson, PhD <dnelson@mimvista.com>
- Eric S. Perlman, MD <perlman@radpharm.com>
- Ling X. Shao, PhD, <ling.shao@philips.com>
- John G. Wolodzko, PhD <wolodzko@radpharm.com>
- Jeffrey Yap, PhD <Jeffrey_Yap@dfci.harvard.edu>
- Brian Zimmerman, PhD <bez@nist.gov>